Age-related macular degeneration, or AMD, is an ocular disease characterized by cellular dysfunction in the macula resulting in significant visual impairment. Initially, the sharp, central vision is impacted but the progression of the disease can lead to complete blindness. While there are two forms of the disease, AMD starts with the dry form characterized by protein deposits called drusen that form on the retina (beneath the macula) causing degeneration of the cells over time.
Approximately, 90% of patients with AMD have the dry form and 10% have the wet form. Valeda is the first approved treatment for dry AMD using photobiomodulation. Until now, the only options for dry AMD patients were lifestyle changes and vitamin supplementation.
AMD and the Importance of Eye Exams
The earlier AMD is diagnosed and monitored by an eye care professional, the better the results will be in treating the disease. An eyecare professional can determine how frequently patients need to be seen for check-ups and treatments based on each patient’s unique vision health and family history.